[Federal Register Volume 75, Number 144 (Wednesday, July 28, 2010)] [Notices] [Page 44285] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2010-18476] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated April 20, 2010, and published in the Federal Register on April 26, 2010, (75 FR 21661), Almac Clinical Services Inc., (ACSI), 2661 Audubon Road, Audubon, Pennsylvania 19403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Oxycodone (9143)........................... II Hydromorphone (9150)....................... II Fentanyl (9801)............................ II ------------------------------------------------------------------------ The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Almac Clinical Services Inc. (ACSI) to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Almac Clinical Services Inc. (ACSI) to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: July 19, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010-18476 Filed 7-27-10; 8:45 am] BILLING CODE 4410-09-P